These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 772808)

  • 1. Beta-lactamase resistance of cephazolin and other cephalosporins.
    Goodwin CS; Hill JP
    Scott Med J; 1976 Sep; 20(5):236-9. PubMed ID: 772808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta lactamase resistance of newer cephalosporins and antimicrobial effectiveness against gram-negative bacilli.
    Farrar WE; O'Dell NM
    Infection; 1977; 5(4):224-7. PubMed ID: 413793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of antibacterial activities of cephalosporin antibiotics: cefazolin, cephaloridine, cephalothin, and cephalexin.
    Hsieh WC; Ho SW
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Mar; 8(1):1-11. PubMed ID: 1097210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium clavulanate potentiation of cephalosporin activity against clinical isolates of cephalothin-resistant Klebsiella pneumoniae.
    Jackson RT; Harris LF; Alford RH
    Antimicrob Agents Chemother; 1978 Jul; 14(1):118-25. PubMed ID: 356723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of cephalosporin resistance in clinical isolates of Escherichia coli.
    Sawai T; Ando-Kuroda I; Murata T; Yamagishi S
    J Pharmacobiodyn; 1980 Jul; 3(7):364-6. PubMed ID: 7009827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activity of cephalosporins on beta-lactamase-producing Neisseria gonorrhoeae.
    Phillips I; Shannon K
    Scand J Infect Dis Suppl; 1978; (13):23-6. PubMed ID: 98833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Microbiological evaluation of cefoxitin, a new beta-lactamase resistant cephamycin antibiotic, compared to cephalothin, cephaloridine and cefazolin].
    Schassan HH; Bentfeld G
    Fortschr Med; 1978 Aug; 96(30):1510-7. PubMed ID: 669547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Another look at differences in the susceptibility of Escherichia coli and Klebsiella pneumoniae to cephalothin and cefazolin.
    Yeh LL; Chi CL
    Int J Antimicrob Agents; 2001 Jun; 17(6):521-4. PubMed ID: 11397625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lytic activity of a new cephalosporin, cefuroxime, against gram-negative bacteria.
    Russell AD; Tottle PC
    Chemotherapy; 1978; 24(6):354-9. PubMed ID: 359269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical bacteriology of cephazolin.
    McAllister TA; Tait SC; Perman MG; Park AC
    Scott Med J; 1976 Sep; 20(5):220-7. PubMed ID: 1265471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between in vitro susceptibility and efficacy in experimental mouse infection-protection assay of cefazolin and cephalothin using Escherichia coli strains.
    Uri JV; Actor P; Phillips L; Guarini JR; Weisbach JA
    Chemotherapy; 1976; 22(5):313-8. PubMed ID: 780071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antistaphylococcal activity and beta-lactamase resistance of newer cephalosporins.
    Farrar WE; Gramling PK
    J Infect Dis; 1976 Jun; 133(6):691-5. PubMed ID: 1047087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro bactericidal action of cefoperazone, cefoxitin, cefuroxime, cefazolin and cephaloridine.
    Piantieri G; Cafarelli A; Magliulo E
    G Batteriol Virol Immunol; 1981; 74(1-6):15-25. PubMed ID: 6458524
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug susceptibility-resistance pattern of gram-negative uropathogens to seven cephalosporins.
    Seneca H
    Am J Med Sci; 1973 Nov; 266(5):381-5. PubMed ID: 4202701
    [No Abstract]   [Full Text] [Related]  

  • 15. Importance of beta-lactamase inactivation in treatment of experimental endocarditis caused by Staphylococcus aureus.
    Goldman PL; Petersdorf RG
    J Infect Dis; 1980 Mar; 141(3):331-7. PubMed ID: 6965978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Microbiological evaluation of the antibacterial activity of cefotaxime in comparison with other cephalosporins].
    Concia E; Marone P; Verani D; Marino P
    Boll Ist Sieroter Milan; 1982; 61(4):300-8. PubMed ID: 6100233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo comparative evaluations of injectable cephalosporin derivatives and ampicillin.
    Gotô S; Kuwahara S
    Chemotherapy; 1976; 22(5):286-96. PubMed ID: 1047636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of seven cephalosporins: susceptibility to beta-lactamases and ability to penetrate the surface layers of Escherichia coli.
    Richmond MH; Wotton S
    Antimicrob Agents Chemother; 1976 Aug; 10(2):219-22. PubMed ID: 791093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vitro spectrum of the cephalosporins.
    Washington JA
    Mayo Clin Proc; 1976 Apr; 51(4):237-50. PubMed ID: 1263595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro bactericidal action of cephalosporins in different concentrations of serum.
    Magliulo E; Ceccarelli G; Bianchi PP; Piantieri G; Cafarelli A
    G Batteriol Virol Immunol; 1981; 74(1-6):39-47. PubMed ID: 6458527
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.